| This article from the literature and clinical research on Artesunate combined with interventional therapy treatment of patients with primary liver cancer,To observe the fluence of immune function and then summed up and concluded.Background:The Chinese medicine thought that this sickness is by the seven emotions,the weary internal injury,the external disease factors excesses of the six factors,eating unclean,the internal organs empty damage,the vitality disagreement,will cause the stagnation of flow of vital energy blood stasis,the mental disorder to condense will become in the course of time."The healthy tendency is insufficient" and external "the perverse trend detention" with in vivo concerns。The modern medicine to the primary liver cancer's from the definition,the epidemiology,etiology,clinical-stage,treatment and other aspects has carried ona great deal of discussion。Primary liver cancer can occur at any age。Misprision of its incidence,rapid development,poor prognosis and seriously endanger human health,to prevent and treat the disease is one of the most important medical and social issues。Chinese medicine used in the treatment of primary liver cancer have been more attempts,by the hepatic artery infusion Traditional Chinese Medicine is one of the methods,it often can play a conventional TACE with the same or a higher treatment result and make side effects smaller。Therefore, in order to increase the involvement of liver cancer treatment result, the development of high efficiency and low toxicity of anti-cancer traditional Chinese medicine,particularly applies the traditional Chinese medicine effective component or the compound prescription in liver cancer involves the treatment the research to cause more and more attention。Objective:To investigate the effect of Artesunate combined with interventional treatment of primary liver cancer and the influences of the immune function in patients。Try to Explores the clinical new anti-tumor traditional Chinese medicine,enhances the traditional Chinese medicine involvement treatment primary liver cancer's curative effect,decreases the involvement treatment the side effects and enhances organism immunity。Method:The study under the People's Republic of China Ministry of Health for medical Secretary of the "Chinese cancer diagnosis and treatment of common standards" on the diagnostic criteria for primary liver cancer in 1991 and liver cancer in 1997 UICC TNM classification standards,selected 60 patients who has been diagnosised for primary liver cancer that treatment in Tumor inpatient department Of Chinese Medicine hospitals in Guangzhou from March 2007 to April 2008,were randomly divided into 30 cases of the treatment group and control group of 30 cases。Two groups give the essential general infusion and the just right for the illness treatment,The treatment group uses the TACE convention plan treatment,combined Artesunate perfusion。The control group uses the TACE convention plan treatment。After a treatment course, acts according to the tumor size change,the AFP change,the immune function target and the liver,the kidney function,white blood cell's change,uses the SPSS12.0 statistics software package to carry on the analysis processing。Results:The treatment group increase in immunity obviously better than the control group(P＜0.05);In narrowing the tumor and reducing effect of AFP broadly similar in both groups(P＞0.05);Intervention in the side-effects,There are not seen the obvious difference between Two groups(P＞0.05)。Conclusion:Artesunate combined intervention therapy can improve patients with primary liver cancer in the body immunity,increase the involvement of liver damage.To Artesunate anti-tumor clinical research have a certain significance。...
|
PDF Full Text Request